Brind.

Getinge Reports Quarterly Earnings; Analysts Maintain 'Hold' Ratings

1 report, 1 independent Updated Wed 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Getinge reported earnings of $0.32 per share for the quarter, with a net margin of 7.81% and a return on equity of 11.12%. The company's market capitalization stands at $7.14 billion. Several research firms have recently adjusted their ratings, including Zacks Research cutting the rating to 'hold' on September 17th, and Nordea Equity Research downgrading the stock on August 31st.

From dailypolitical.com

Why it matters

Some supportBrind's analysis of the reports

The earnings report provides insight into the financial health of the medical technology company. The consensus rating among analysts is currently 'hold,' reflecting market sentiment regarding the company's valuation and future performance.

From dailypolitical.com

Who's involved

  • GetingeMedical technology company that issued the earnings report
  • SwedenCountry where Getinge is based

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped